1. Sklar SH, Blue WT, Alexander EJ, et al. Herpes zoster. The treatment
and prevention of neuralgia with adenosine monophosphate. JAMA 1985;253:1427-30. 2. Gajdos A. AMP in porphyria cutanea tarda. Lancet 1974;I:163
[letter]. 3. Bakshi F, Barzilay Z, Paret G, Hashomer T. Adenosine in the diagnosis
and treatment of narrow complex tachycardia in the pediatric intensive care unit. Heart
Lung 1998;27:47-50. 4. Camaiti A, Del Rosso A, Morettini A, et al. Efficacy and safety of
adenosine in diagnosis and treatment of regular tachycardia in the elderly. Coron Artery
Dis 1998;9:591-6. 5. Schrader J, Deussen A, Smolenski RT. Adenosine is a sensitive oxygen
sensor in the heart. Experientia 46:1172-5. 6. Headrick J, Willis RJ. Endogenous adenosine improves work rate to
oxygen consumption ratio in catecholamine stimulated isovolumic rat heart. Pflugers
Arch 1989;413:354-8. 7. Finegan BA, Clanachan AS, Coulson CS, Lopaschunk GD. Adenosine
modification of energy substrate use in isolated hearts perfused with fatty acids. Am J
Physiol 1992;262:H1501-7. 8. Sklar SH. Herpes virus infection. JAMA
1977;237:871–2. 9. Sherlock CH, Corey L. Adenosine monophosphate for the treatment of
varicella zoster infections: A large dose of caution. JAMA 1985;253:1444–5. 10. Gaby AR, Wright JV. Nutritional Therapy in Medical Practice.
Proceedings from Nutritional Therapy in Medical Practice Conference,
Seattle, WA, Oct 25–8, 1996, 33; gaby@halcyon.com. |